Quoin Pharmaceuticals, Ltd. - QNRX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G ADAR1 Capital Management, LLC 6.9% 58,230 View
Feb 17, 2026 SCHEDULE 13G ADAR1 Capital Management GP, LLC 6.0% 50,226 View
Feb 17, 2026 SCHEDULE 13G Daniel Schneeberger 6.9% 58,230 View
Feb 17, 2026 SCHEDULE 13G Woodline Partners LP 9.5% 2,785,370 View
Feb 11, 2026 SCHEDULE 13G/A Integrated Core Strategies (US) LLC 4.6% 2,618,595 View
Feb 11, 2026 SCHEDULE 13G/A Millennium Management LLC 4.6% 2,618,595 View
Feb 11, 2026 SCHEDULE 13G/A Millennium Group Management LLC 4.6% 2,618,595 View
Feb 11, 2026 SCHEDULE 13G/A Israel A. Englander 4.6% 2,618,595 View
Feb 06, 2026 SCHEDULE 13G/A Ikarian Capital, LLC 12.6% 211,538 View
Feb 06, 2026 SCHEDULE 13G/A Neil Shahrestani 12.6% 211,538 View
Feb 02, 2026 SCHEDULE 13G/A Stonepine Capital Management, LLC 10.6% 3,271,100 View
Feb 02, 2026 SCHEDULE 13G/A Stonepine Capital, L.P. 10.6% 3,271,100 View
Feb 02, 2026 SCHEDULE 13G/A Stonepine GP, LLC 10.6% 3,271,100 View
Feb 02, 2026 SCHEDULE 13G/A Jon M. Plexico 10.6% 3,271,100 View
Jan 28, 2026 SCHEDULE 13G Aberdeen Group plc 8.94% 75,000 View
Jan 28, 2026 SCHEDULE 13G abrdn Inc. 8.94% 75,000 View
Dec 16, 2025 SCHEDULE 13G Stonepine Capital Management, LLC 9.9% 3,030,926 View
Dec 16, 2025 SCHEDULE 13G Stonepine Capital, L.P. 9.9% 3,030,926 View
Dec 16, 2025 SCHEDULE 13G Stonepine GP, LLC 9.9% 3,030,926 View
Dec 16, 2025 SCHEDULE 13G Jon M. Plexico 9.9% 3,030,926 View
Dec 15, 2025 SCHEDULE 13G Ikarian Capital, LLC 25.2% 211,538 View
Dec 15, 2025 SCHEDULE 13G Neil Shahrestani 25.2% 211,538 View
Dec 11, 2025 SCHEDULE 13G Resolute Capital Asset Partners LLC 8.5% 50,000 View
Dec 11, 2025 SCHEDULE 13G Resolute Capital Asset Partners Fund I LP 8.5% 50,000 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.